These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2016630)

  • 1. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
    Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
    J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.
    Lamy T; Michelet C; Dauriac C; Grulois I; Donio PY; Le Prisé PY
    Acta Haematol; 1993; 90(3):109-13. PubMed ID: 8291367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients].
    Maraninchi D; Hartman O; Benhamou E; Viens P; Blaise D; Vassal G; Gaspard MH; Kalifa C; Stoppa AM; Patte C
    Pathol Biol (Paris); 1988 Sep; 36(7):915-9. PubMed ID: 3059277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
    Vassilomanolakis M; Plataniotis G; Koumakis G; Hajichristou H; Skouteri H; Dova H; Efremidis AP
    Bone Marrow Transplant; 1995 Jan; 15(1):77-80. PubMed ID: 7742759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective?
    Niederhäuser U; Vogt M; Vogt P; Genoni M; Künzli A; Turina MI
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):162-8. PubMed ID: 9270631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
    Bosi A; Laszlo D; Bacci S; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi-Ferrini P
    J Chemother; 1999 Aug; 11(4):287-92. PubMed ID: 10465131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].
    Rubie H; Attal M; Lemozy J; Massip P; Huguet F; Pris J; Robert A; Régnier C
    Pathol Biol (Paris); 1988 Sep; 36(7):912-4. PubMed ID: 3059276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
    Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
    J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin.
    Teinturier C; Hartmann O; Lemerle J; Benhamou E; Maraninchi D
    Pediatr Hematol Oncol; 1995; 12(1):73-7. PubMed ID: 7703045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
    Schots R; Trullemans F; Van Riet I; Kaufman L; Hafsia A; Meddeb B; Hadj Ali ZB; Ben Abid H; Lauwers S; Van Camp B
    Transplantation; 2000 Apr; 69(7):1511-4. PubMed ID: 10798782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
    Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
    Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics.
    Petersen FB; Buckner CD; Clift RA; Nelson N; Counts GW; Meyers JD; Thomas ED
    Scand J Infect Dis; 1987; 19(5):559-67. PubMed ID: 3321413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia.
    Karp JE; Dick JD; Angelopulos C; Charache P; Green L; Burke PJ; Saral R
    Am J Med; 1986 Aug; 81(2):237-42. PubMed ID: 3526884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
    Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
    Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections and bone marrow autograft carried out for leukemias in children. Apropos of 47 cases].
    Amsallem D; Plouvier E; Estavoyer JM; Leroy J; Talon D; Lab M; Hervé P; Noir A
    Arch Fr Pediatr; 1988; 45(6):393-7. PubMed ID: 3064729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.